Madrigal Pharmaceuticals, Inc.

NASDAQ (USD): Madrigal Pharmaceuticals, Inc. (MDGL)

Last Price

284.49

Today's Change

+1.03 (0.36%)

Day's Change

276.63 - 289.91

Trading Volume

165,091

Overview

Market Cap

6 Billion

Shares Outstanding

21 Million

Avg Volume

439,329

Avg Price (50 Days)

262.19

Avg Price (200 Days)

223.79

PE Ratio

-12.29

EPS

-23.14

Earnings Announcement

07-Aug-2024

Previous Close

283.46

Open

287.67

Day's Range

276.63 - 289.9115

Year Range

119.76 - 299.98

Trading Volume

165,091

Price Change Highlight

1 Day Change

0.36%

5 Day Change

1.12%

1 Month Change

3.32%

3 Month Change

47.15%

6 Month Change

25.90%

Ytd Change

25.40%

1 Year Change

41.30%

3 Year Change

233.05%

5 Year Change

237.07%

10 Year Change

102.20%

Max Change

-10.58%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment